These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 21106735)

  • 1. HIV-1 maturation inhibitor bevirimat stabilizes the immature Gag lattice.
    Keller PW; Adamson CS; Heymann JB; Freed EO; Steven AC
    J Virol; 2011 Feb; 85(4):1420-8. PubMed ID: 21106735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of an HIV-1 maturation inhibitor on the structure and dynamics of CA-SP1 junction helices in virus-like particles.
    Gupta S; Louis JM; Tycko R
    Proc Natl Acad Sci U S A; 2020 May; 117(19):10286-10293. PubMed ID: 32341150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to Second-Generation HIV-1 Maturation Inhibitors.
    Urano E; Timilsina U; Kaplan JA; Ablan S; Ghimire D; Pham P; Kuruppu N; Mandt R; Durell SR; Nitz TJ; Martin DE; Wild CT; Gaur R; Freed EO
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30567982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alkyl Amine Bevirimat Derivatives Are Potent and Broadly Active HIV-1 Maturation Inhibitors.
    Urano E; Ablan SD; Mandt R; Pauly GT; Sigano DM; Schneider JP; Martin DE; Nitz TJ; Wild CT; Freed EO
    Antimicrob Agents Chemother; 2016 Jan; 60(1):190-7. PubMed ID: 26482309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic Studies and Modeling Reveal the Origin of Differential Inhibition of Gag Polymorphic Viruses by HIV-1 Maturation Inhibitors.
    Lin Z; Cantone J; Lu H; Nowicka-Sans B; Protack T; Yuan T; Yang H; Liu Z; Drexler D; Regueiro-Ren A; Meanwell NA; Cockett M; Krystal M; Lataillade M; Dicker IB
    PLoS Pathog; 2016 Nov; 12(11):e1005990. PubMed ID: 27893830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into the mechanism of action of EP-39, a bevirimat derivative that inhibits HIV-1 maturation.
    Neyret A; Gay B; Cransac A; Briant L; Coric P; Turcaud S; Laugâa P; Bouaziz S; Chazal N
    Antiviral Res; 2019 Apr; 164():162-175. PubMed ID: 30825471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic susceptibility to bevirimat in isolates from HIV-1-infected patients without prior exposure to bevirimat.
    Margot NA; Gibbs CS; Miller MD
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2345-53. PubMed ID: 20308382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prototype HIV-1 maturation inhibitor, bevirimat, binds to the CA-SP1 cleavage site in immature Gag particles.
    Nguyen AT; Feasley CL; Jackson KW; Nitz TJ; Salzwedel K; Air GM; Sakalian M
    Retrovirology; 2011 Dec; 8():101. PubMed ID: 22151792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single G10T polymorphism in HIV-1 subtype C Gag-SP1 regulates sensitivity to maturation inhibitors.
    Ghimire D; Kc Y; Timilsina U; Goel K; Nitz TJ; Wild CT; Gaur R
    Retrovirology; 2021 Apr; 18(1):9. PubMed ID: 33836787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and functional insights into the HIV-1 maturation inhibitor binding pocket.
    Waki K; Durell SR; Soheilian F; Nagashima K; Butler SL; Freed EO
    PLoS Pathog; 2012; 8(11):e1002997. PubMed ID: 23144615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in Gag spacer peptide 1 confer varying levels of resistance to the HIV- 1 maturation inhibitor bevirimat.
    Adamson CS; Sakalian M; Salzwedel K; Freed EO
    Retrovirology; 2010 Apr; 7():36. PubMed ID: 20406463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an HIV-1 Mutation in Spacer Peptide 1 That Stabilizes the Immature CA-SP1 Lattice.
    Fontana J; Keller PW; Urano E; Ablan SD; Steven AC; Freed EO
    J Virol; 2016 Jan; 90(2):972-8. PubMed ID: 26537676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single polymorphism in HIV-1 subtype C SP1 is sufficient to confer natural resistance to the maturation inhibitor bevirimat.
    Lu W; Salzwedel K; Wang D; Chakravarty S; Freed EO; Wild CT; Li F
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3324-9. PubMed ID: 21502630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The capsid-spacer peptide 1 Gag processing intermediate is a dominant-negative inhibitor of HIV-1 maturation.
    Checkley MA; Luttge BG; Soheilian F; Nagashima K; Freed EO
    Virology; 2010 Apr; 400(1):137-44. PubMed ID: 20172577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a Structural Element in HIV-1 Gag Required for Virus Particle Assembly and Maturation.
    Novikova M; Adams LJ; Fontana J; Gres AT; Balasubramaniam M; Winkler DC; Kudchodkar SB; Soheilian F; Sarafianos SG; Steven AC; Freed EO
    mBio; 2018 Oct; 9(5):. PubMed ID: 30327442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two-pronged structural analysis of retroviral maturation indicates that core formation proceeds by a disassembly-reassembly pathway rather than a displacive transition.
    Keller PW; Huang RK; England MR; Waki K; Cheng N; Heymann JB; Craven RC; Freed EO; Steven AC
    J Virol; 2013 Dec; 87(24):13655-64. PubMed ID: 24109217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural analysis of HIV-1 maturation using cryo-electron tomography.
    de Marco A; Müller B; Glass B; Riches JD; Kräusslich HG; Briggs JA
    PLoS Pathog; 2010 Nov; 6(11):e1001215. PubMed ID: 21151640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroED structures of HIV-1 Gag CTD-SP1 reveal binding interactions with the maturation inhibitor bevirimat.
    Purdy MD; Shi D; Chrustowicz J; Hattne J; Gonen T; Yeager M
    Proc Natl Acad Sci U S A; 2018 Dec; 115(52):13258-13263. PubMed ID: 30530702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro resistance to the human immunodeficiency virus type 1 maturation inhibitor PA-457 (Bevirimat).
    Adamson CS; Ablan SD; Boeras I; Goila-Gaur R; Soheilian F; Nagashima K; Li F; Salzwedel K; Sakalian M; Wild CT; Freed EO
    J Virol; 2006 Nov; 80(22):10957-71. PubMed ID: 16956950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Inositol Hexakisphosphate on HIV-1 Particle Production and Infectivity can be Modulated by Mutations that Affect the Stability of the Immature Gag Lattice.
    Kleinpeter AB; Zhu Y; Mallery DL; Ablan SD; Chen L; Hardenbrook N; Saiardi A; James LC; Zhang P; Freed EO
    J Mol Biol; 2023 Jun; 435(11):168037. PubMed ID: 37330292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.